Home Newsfeeds JP Morgan Upgrades Amphenol to Overweight

JP Morgan Upgrades Amphenol to Overweight

JP Morgan analyst Samik Chatterjee upgrades Amphenol (NYSE:APH) from Neutral to Overweight.

byBenzinga Newsdesk

July 14, 2022

1 minute read

JP Morgan analyst Samik Chatterjee upgrades Amphenol (NYSE:APH) from Neutral to Overweight.

Why Safe And Green Development Stock Gained Today

By Ryan Gustafson

November 21, 3:49 PM

Safe and Green Development Corporation (NASDAQ: SGD) shares are trading higher on Tuesday after the company signed a non-binding Letter of Intent to invest money in Majestic World Holdings in exchange for access to the

SGD

U.S. FDA Accepts Acadia’s Filing For Rett Syndrome Candidate Under Priority Review

By Ragothaman Srinivasan

September 12, 9:15 AM

The U.S. Food and Drug Administration (FDA) has accepted for filing Acadia Pharmaceuticals’ (NASDAQ: ACAD) New Drug Application (NDA) of trofinetide for the treatment of Rett syndrome. The regulatory agency has granted a priority review and assigned a PDUFA action date of March 12, 2023.

ACAD

Analyst Ratings

Expert Ratings for SmartRent

By Benzinga Insights

June 20, 11:00 AM

SmartRent (NYSE:SMRT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

SMRT

Meta, Amazon, Nvidia, AMD, Ford: Why These Five Stocks Are On Investors’ Radars Today

By Benzinga Neuro

October 25, 9:57 PM

U.S. stocks showcased a downward trend as trading neared its end on Wednesday. The Dow Jones index witnessed a decline of over 100 points, marking a 0.32% drop to 33,035.93.

AMD

JP Morgan Upgrades Amphenol to Overweight

Related Posts

Why Safe And Green Development Stock Gained Today

U.S. FDA Accepts Acadia’s Filing For Rett Syndrome Candidate Under Priority Review

Expert Ratings for SmartRent

Meta, Amazon, Nvidia, AMD, Ford: Why These Five Stocks Are On Investors’ Radars Today